Proinsulin Promotes Tumor Development in the PANC-1 Pancreatic Adenocarcinoma Cell Line
Anticancer Research · 2026
DOI: 10.21873/anticanres.18130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Tomonori Tsuyama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Metabolic Regulation of Healthy Aging (CMHA), Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; t-tsuyama@kumamoto-u.ac.jp. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Receptor, Insulin, Proinsulin, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: Epidemiological studies have demonstrated that type 2 diabetes mellitus (T2DM) is a risk factor for pancreatic ductal adenocarcinoma (PDAC); however, the underlying mechanisms remain unclear. Recent studies have suggested a potential link between proinsulin, a prohormone of insulin, and cancer. In this study, we examined the tumorigenic effects of proinsulin in PDAC. MATERIALS AND METHODS: We measured the expression levels of the insulin receptor (IR) gene isoforms IR-A and IR-B in tumor samples from 5 patients with PDAC and in the human PANC-1 pancreatic adenocarcinoma cell line using reverse transcription-PCR. We then assessed the effect of proinsulin treatment on ERK and AKT phosphorylation in PANC-1 cells using western blotting. We also evaluated the effect of proinsulin treatment on cell proliferation, resistance to an anti-cancer drugs, and cell invasion using direct cell counting and a WST-1 assay, an annexin/propidium iodine cell death detection assay, and an invasion assay, respectively. Finally, we used RNA sequencing and quantitative reverse transcription-PCR to identify genes whose expression was altered by proinsulin treatment. RESULTS: IR-A was expressed in tumor tissues from four out of five PDAC patients and in PANC-1 cells. Proinsulin stimulation significantly increased ERK1/2 phosphorylation in PANC-1 cells and also increased AKT phosphorylation, albeit to a lesser extent. Proinsulin stimulation significantly induced cell proliferation, protected against staurosporine-induced apoptosis, and promoted PANC-1 cell invasion. Consistent with these results, proinsulin stimulation upregulated the expression of genes related to cell proliferation, anti-cancer drug resistance, and cell invasion in PANC-1 cells. CONCLUSION: Proinsulin may promote PDAC tumor development by binding to IR-A and activating the ERK pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Metabolic Regulation of Healthy Aging (CMHA), Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; t-tsuyama@kumamoto-u.ac.jp.
- Department of Medical Biochemistry, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Gastroenterological Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
- Center for Metabolic Regulation of Healthy Aging (CMHA), Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Zitieren
APA
Tsuyama, T., Dong, H., Sato, T., Okabe, H., Hayashi, H., Iwatsuki, M., & Yamagata, K. (2026). Proinsulin Promotes Tumor Development in the PANC-1 Pancreatic Adenocarcinoma Cell Line. Anticancer Research. https://doi.org/10.21873/anticanres.18130
Vancouver
Tsuyama T, Dong H, Sato T, Okabe H, Hayashi H, Iwatsuki M, et al. Proinsulin Promotes Tumor Development in the PANC-1 Pancreatic Adenocarcinoma Cell Line. Anticancer Research. 2026. doi:10.21873/anticanres.18130
BibTeX
@article{Tsuyama2026,
author = {Tsuyama, Tomonori and Dong, Hanchen and Sato, Takenari and Okabe, Hirohisa and Hayashi, Hiromitsu and Iwatsuki, Masaaki and Yamagata, Kazuya},
title = {Proinsulin Promotes Tumor Development in the PANC-1 Pancreatic Adenocarcinoma Cell Line},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18130}
}
EUVIMED